• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

July 10, 2012

Chronic Painkiller Abuse, Methadone-Related Deaths Both Increasingly Common

Author(s):

Daniel Weiss, Senior Editor

Recent research from the CDC finds that chronic abuse of prescription painkillers has leaped in recent years and methadone is disproportionately associated with prescription painkiller deaths.

Recent research from the CDC finds that chronic abuse of prescription painkillers has leaped in recent years and methadone is disproportionately associated with prescription painkiller deaths.

In the last decade, chronic prescription painkiller abuse rates have increased dramatically, and methadone has come to play a major role in causing prescription painkiller overdose deaths, according to 2 recent reports from researchers at the Centers for Disease Control and Prevention (CDC).

In 2009, 15,597 people in the United States died of overdoses involving the painkillers oxycodone, hydrocodone, and methadone, an increase of 109% since 2002. However, estimates of the overall rates of abuse of these drugs have not changed over this time span. To determine whether changes in the rate of chronic painkiller abuse could help explain the increase in overdose deaths, Christopher Jones, PharmD, MPH, of the CDC, looked at data from the National Survey on Drug Use and Health from 2002-2003 and 2009-2010.

His study’s results, published online on June 25, 2012, in Archives of Internal Medicine, found that the portion of people who abused prescription painkillers at least 200 days out of the year leaped from 2.2 per 1000 people in 2002-2003 to 3.8 per 1000 people in 2009-2010—an increase of 74.6%. During the same period, the overall portion of people who abused prescription painkillers at any frequency did not change significantly.

The increase in chronic prescription painkiller abuse was particularly steep among men (105.3%), among those between the ages of 26 and 34 (81.0%), and among those between the ages of 35 and 49 (134.6%). Dr. Jones notes that these rates of increase parallel the increases in overdose death rates for these groups. The study did find one bright spot: The rate of overall prescription painkiller abuse for adolescents between the ages of 12 and 17 fell 15.5% between 2002-2003 and 2009-2010.

Further clues to the increase in deaths associated with prescription painkiller abuse are found in the July 2012 issue of CDC Vital Signs. It notes that methadone accounted for just 2% of painkiller prescriptions in 2009 but was involved in more than 30% of prescription painkiller overdose deaths that year. These findings are based on national data from 1999 to 2010 and 2009 data from the 13 states covered by the Drug Abuse Warning Network of the Substance Abuse and Mental Health Services Administration, a surveillance system for drug-related deaths.

The report notes that methadone has been used for years to treat drug addiction, but is now increasingly prescribed as a painkiller as well. As methadone prescriptions to treat pain have increased—to 4 million in 2009—so have methadone abuse and fatal overdoses involving the drug, which increased 6-fold between 1999 and 2009. Methadone is particularly risky because it builds up in the body’s system and can disrupt a user’s breathing and heart rhythm. In addition, the difference between an appropriate dose and a dangerous dose of the drug is very small.

Despite recent efforts to warn health care providers of the potential dangers associated with methadone, the number of prescriptions for the drug to treat pain has not declined significantly. One reason for methadone’s popularity is that it is available as a low-cost generic drug and is on the list of preferred drugs for many insurance companies. Another challenge for those trying to raise awareness of the drug’s dangers is that the majority of methadone prescriptions for pain relief are written by providers who lack special training in pain management.

For more information on this topic, click on the following links:

  • Prescription Drug Overdoses Reach Epidemic Levels
  • Adolescent Painkiller Abuse Likely to Begin During High School
  • Opioid Dependence Hits Maternity Wards and NICUs
  • New York State Set to Crack Down on Painkiller Abuse
  • New Painkillers--Friend or Foe?
  • Friends and Family Frequently Provide Pills to Prescription Drug Abusers

Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Plaque buildup in artery | Image Credit: © SK imagine - stock.adobe.com
May 8th 2025

Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
U.S. House of Representatives, Washington, DC USA
May 8th 2025

Coalition of Pharmacy Organizations Urges Congress to Pass ECAPS Legislation

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
GLP-1 and Side Effects newspaper headlines with magnifying glass
May 8th 2025

Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications

Luke Halpern, Assistant Editor
Wegovy injection pen | Image Credit: © Patrick Bay Damsted - stock.adobe.com
May 7th 2025

GLP-1 Drugs Show Promise in Lowering Health Care Costs, Report Says

Alexandra Gerlach, Associate Editor
Related Content
Advertisement
Plaque buildup in artery | Image Credit: © SK imagine - stock.adobe.com
May 8th 2025

Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
U.S. House of Representatives, Washington, DC USA
May 8th 2025

Coalition of Pharmacy Organizations Urges Congress to Pass ECAPS Legislation

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
GLP-1 and Side Effects newspaper headlines with magnifying glass
May 8th 2025

Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications

Luke Halpern, Assistant Editor
Wegovy injection pen | Image Credit: © Patrick Bay Damsted - stock.adobe.com
May 7th 2025

GLP-1 Drugs Show Promise in Lowering Health Care Costs, Report Says

Alexandra Gerlach, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.